QQ客服 官方微博 反馈留言

	Superiority of prophylaxis versus on-demand therapy with plasma protein-free recombinant FVIII formulated with sucrose (BAY 81-8973): LEOPOLD II study results
	Kavakli, Kaan; Yang, Renchi; Rusen, Luminita; Beckmann, Horst; Tseneklidou-Stoeter, Despina; Enriquez, Monika Maas
	2014
卷号	20期号:,SI页码:94-95
ISSN号	1351-8216
URL标识	查看原文
收录类别	SCIE
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6683310
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Kavakli, Kaan,Yang, Renchi,Rusen, Luminita,et al. Superiority of prophylaxis versus on-demand therapy with plasma protein-free recombinant FVIII formulated with sucrose (BAY 81-8973): LEOPOLD II study results[J],2014,20(,SI):94-95.
APA	Kavakli, Kaan,Yang, Renchi,Rusen, Luminita,Beckmann, Horst,Tseneklidou-Stoeter, Despina,&Enriquez, Monika Maas.(2014).Superiority of prophylaxis versus on-demand therapy with plasma protein-free recombinant FVIII formulated with sucrose (BAY 81-8973): LEOPOLD II study results.,20(,SI),94-95.
MLA	Kavakli, Kaan,et al."Superiority of prophylaxis versus on-demand therapy with plasma protein-free recombinant FVIII formulated with sucrose (BAY 81-8973): LEOPOLD II study results".20.,SI(2014):94-95.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。